That is why the current wave of fake Ozempic-style drugs now circulating in the U.S by unlicensed and often foreign companies ...

Eli Lilly (LLY) reported first quarter earnings beating Wall Street's expectations Thursday on the top and bottom lines, but GLP-1 sales weren't as strong as expected. Lilly reported adjusted earnings ...

But that could be threatened by an announcement Thursday that one of the country's largest pharmacy benefit managers ... A syringe and pills are in front of the logo of Eli Lilly pharmaceutical ...

The relative lack of regulation in this space came to the forefront in 2013, after a contaminated steroid injectable, manufactured by a compounding pharmacy in Massachusetts, triggered a multi ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, ...

They are not FDA-approved medications but the agency monitors and conducts for-cause inspections of compounding pharmacies, which are typically regulated by state boards of pharmacy. The agency ...

Domino's earnings sending the same warning signals as Chipotle-- lower-income people aren't ordering as often. Temu and Shein pushing tariff increases to American consumers. Old Dominion Freight ...

Compounding is the secret to how the rich get richer. Or, as Benjamin Franklin put it, “Money makes money. And money that makes money, makes money.” Fortunately, you don’t need to start rich ...

Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the ...